Font Size: a A A

Studies On The Mechanism Of Dracorhodin Perchlorate And Magnolol-induced Tumor Cell Apoptosis

Posted on:2005-11-22Degree:DoctorType:Dissertation
Country:ChinaCandidate:M Y XiaFull Text:PDF
GTID:1104360185489111Subject:Pharmacology
Abstract/Summary:PDF Full Text Request
This dissertation reports mechanisms of dracorhodin perchlorate-induced cell death in human cervical carcinoma HeLa, human melanoma A375-S2, and human premyelocytic leukemia HL-60 cells and mechanism of magnolol-induced HeLa cell death.The studies demonstrate that dracorhodin perchlorate inhibited the proliferation of A375-S2, HeLa, HL-60, human breast cancer MCF-7 and human histocytic lymphoma U937 cells in a dose- and time-dependent manner. MTT assay, photomicroscopical observation and DNA agarose gel electrophoresis showed that dracorhodin perchlorate induced cell apoptosis in HeLa, A375-S2 and HL-60 cells.In dracorhodin perchlorate-treated HeLa cells caspase-3, 8, 9 activities increased followed by the degradation of caspase-3 substrates, ICAD (inhibitor of caspase dependent DNase) and PARP (poly-(ADP-ribose) polymerase). Caspase 1 inhibitor, Ac-YVAD-cmk, and a caspase 10 inhibitor z-AEVD-fmk also reduced dracorhodin perchlorate-induced HeLa cell death. Fas expression was up-regulated and the Fas agonistic antibody CH-11 has a synergistic effect with dracorhodin perchlorate. The drug decreased the expression of anti-apoptotic mitochondrial protein, Bcl-XL, but not Bcl-2, increased the expression of pro-apoptotic protein, Bax. It also caused the lost of mitochondrial membrane potential. Pretreatment with Ac-YVAD-cmk reduced DNA fragmentation, attenuated degradation of procaspase-3 and its substrates, ICAD and PARP, however, it did not affect the activation of caspase-8; suggesting caspase-1 may play its role upstream to caspase-3 in dracorhodin perchlorate induced HeLa cell apoptosis. Dracorhodin perchlorate increased the expression of p53 and p21WAF1 proteins. The cell death was partially reduced by MEK inhibitor (PD98059), JNK MAPK inhibitor (SP600125) and p38 MAPK inhibitor (SB 203580); the drug induced sustained phosphorylation of JNK, phosphorylation of ERK at 3~6 h, and phosphorylation of p38 at 24~36 h, indicating different roles of these MAPK at different stages of cell death.In dracorhodin perchlorate-treated A375-S2 cells, caspase-3, -8, -9, and -10...
Keywords/Search Tags:dracorhodin perchlorate, magnolol, caspase family, Bcl-2 family, MAPK family, Fas, p53
PDF Full Text Request
Related items